KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Research & Development (2016 - 2025)

Historic Research & Development for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $115.9 million.

  • Zimmer Biomet Holdings' Research & Development rose 385.3% to $115.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $448.3 million, marking a year-over-year increase of 137.95%. This contributed to the annual value of $437.4 million for FY2024, which is 464.36% down from last year.
  • Zimmer Biomet Holdings' Research & Development amounted to $115.9 million in Q3 2025, which was up 385.3% from $113.3 million recorded in Q2 2025.
  • In the past 5 years, Zimmer Biomet Holdings' Research & Development registered a high of $165.0 million during Q2 2021, and its lowest value of $81.0 million during Q1 2021.
  • For the 5-year period, Zimmer Biomet Holdings' Research & Development averaged around $109.4 million, with its median value being $109.4 million (2024).
  • Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 8897.64% in 2021, then crashed by 3975.76% in 2022.
  • Over the past 5 years, Zimmer Biomet Holdings' Research & Development (Quarter) stood at $96.0 million in 2021, then rose by 12.5% to $108.0 million in 2022, then increased by 4.91% to $113.3 million in 2023, then decreased by 4.24% to $108.5 million in 2024, then increased by 6.82% to $115.9 million in 2025.
  • Its Research & Development was $115.9 million in Q3 2025, compared to $113.3 million in Q2 2025 and $110.6 million in Q1 2025.